I was a bit snappy this afternoon. Apologies to all.
Here are the genomics/bioinfo. stocks, 10/11/99 -> 3/3/00 (% change)
1. aria...7100
2. hysq...2080
3. glgc...1877
4. gene...1338
5. incy...1166
6. crgn...1145
7. mygn....751
8. absc....724
9. genxy....522
10. cra.....486
11. vgin....425
12. hgsi...380
13. mlnm..208
14. affx...197
Mike: my point about GLIA and other heavily promoted SI biotech stocks is amply revealed in your post. Gliatech has got to be one of the WORST performing biotech stocks during the last ~8 weeks. In a sector where virtually EVERY STOCK HAS GONE UP 2X, 3X, and more, GLIA has done virtually nothing. Nonetheless, it continues to be advertised as nirvana...and continues to underperform. Meanwhile Ariad, which has been far outpacing its peers since October, DOUBLED SINCE LAST FRIDAY.
In short, I strongly disagree with your assessment of GLIA: underperforming stocks tend to behave that way for a reason..and will likely continue to do poorly. The opposite for overachievers. Glia is heavily promoted on SI (along with NRGN, NBIX, BTRN, etc.), Ariad is rarely mentioned beyond this thread.
This should strike you right at your 'core'. |
